Apotex Corp Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Apotex Corp Pharmaceutical Import Records from India — 4 Products, $37.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Apotex Corp — Pharmaceutical Importer Profile (2026) | 4 Products, $37.3M Trade | TransData Nexus

Apotex Corp

Pharmaceutical Importer · United States · Cardiovascular Focus · $37.3M Total Trade · DGFT Verified

Apotex Corp is a pharmaceutical importer based in United States with a total trade value of $37.3M across 4 products in 4 therapeutic categories. Based on 746 verified import shipments from Indian Customs (DGFT) records, Apotex Corp is the #1 buyer in 2 products including Atorvastatin, Protein. Apotex Corp sources from 7 verified Indian suppliers, with Piramal Pharma Limited accounting for 64.2% of imports.

Apotex Corp — Import Portfolio & Supplier Network

Apotex Corp import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Apotex Corp?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Piramal Pharma Limited	$21.7M	501	64.2%
Apotex Research Private Limited	$4.3M	101	12.7%
Msn Laboratories Private Limited	$2.4M

What Formulations Does Apotex Corp Import?

Formulation	Value	Ships
(401291027) atorvastatin calcium	$1.2M	26
Vilazodone fct 40MG 30s	$800.0K	16
(401291022) atorvastatin fct 20MG 90	$780.8K	16
(401291020) atorvastatin fct 10MG 90	$500.0K	10
Regadenoson injection 0.4 MG/5 ML 0.08MG/ML	$500.0K	10
(401291024) atorvastatin calcium	$483.6K	10
401291027 atorvastatin calcium	$477.0K	10
(401291024)atorvastatin calcium	$450.0K	9
401291025 atorvastatin fct 40MG 1000	$450.0K	9
(401291021) atorvastatin calcium	$400.0K	8
401291026 atorvastatin calcium tabs	$376.4K	8
Regadenoson injection 0.4 MG/5 ML	$350.0K	7
(401291023) atorvastatin fct 20MG 1000	$344.0K	8
Vilazodone fct 20MG 30s	$302.3K	7
(401291026) atorvastatin calcium tabs	$277.6K	6

Apotex Corp imports 492 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Atorvastatin	Cardiovascular	$21.4M	429	2.0%	1
2	Calcium	Vitamins & Supplements	$14.4M	289	1.6%	2
3	Paclitaxel	Oncology	$700.0K	14	0.8%	3
4	Protein	Nutritional Supplements	$700.0K	14	4.7%	1

Apotex Corp imports 4 pharmaceutical products across 4 categories into United States totaling $37.3M. The company is the #1 buyer for 2 products: Atorvastatin, Protein.

Apotex Corp — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Apotex Corp. is a U.S.-based pharmaceutical company specializing in the importation and distribution of generic medications. Headquartered in Weston, Florida, Apotex Corp. operates as an affiliate of Apotex Inc., a Canadian multinational pharmaceutical corporation. Apotex Inc., founded in 1974 by Barry Sherman, is the largest producer of generic drugs in Canada, with annual sales exceeding $1 billion. The company employs approximately 8,000 people and offers over 300 products in more than 115 countries.

In the United States, Apotex Corp. plays a significant role in the pharmaceutical supply chain by providing affordable, high-quality generic medications across various therapeutic areas. The company's product portfolio includes treatments for conditions such as cancer, diabetes, high cholesterol, glaucoma, infections, and hypertension. Apotex Corp. is committed to improving patient access to essential medicines, thereby enhancing healthcare affordability and availability.

2Distribution Network

Apotex Corp. maintains a robust distribution network within the United States to ensure efficient delivery of its pharmaceutical products. While specific warehouse locations are not publicly disclosed, the company utilizes a combination of regional distribution centers and third-party logistics providers to manage inventory and fulfill orders nationwide. This strategic approach enables Apotex Corp. to meet the diverse needs of healthcare providers and patients across the country.

Beyond the U.S., Apotex Inc., the parent company, has a global presence with manufacturing facilities and offices in countries such as Canada, Mexico, and India. This international footprint supports the company's ability to source raw materials and finished products efficiently, contributing to its capacity to supply a wide range of generic medications to various markets.

3Industry Role

In the United States pharmaceutical supply chain, Apotex Corp. functions primarily as a pharmaceutical importer and distributor. The company sources generic medications from various international manufacturers, including those in India, and supplies them to wholesalers, healthcare providers, and pharmacies across the U.S. By focusing on the importation and distribution of generic drugs, Apotex Corp. plays a crucial role in enhancing the accessibility and affordability of essential medications for American patients.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Apotex Corp

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Apotex Corp.'s sourcing strategy reveals a significant concentration in its supplier base, particularly from India. The company's total import value from India amounts to $37.3 million USD, encompassing 746 shipments across four therapeutic categories. Notably, Apotex Corp. is the leading buyer of atorvastatin and protein formulations, with imports valued at $21.4 million USD and $700,000 USD, respectively. This concentration indicates a strategic focus on specific suppliers and products, which can offer benefits such as favorable pricing and consistent product quality.

However, this dependency also introduces potential risks, including supply chain disruptions due to geopolitical events, regulatory changes, or natural disasters affecting the supplier regions. The stability of Apotex Corp.'s relationships with its Indian suppliers is crucial to mitigate these risks. The company's diversified product portfolio, with 492 unique formulations imported, suggests an effort to balance its sourcing strategy and reduce over-reliance on a single supplier or product line.

2Supply Chain Resilience

Apotex Corp.'s supply chain resilience is influenced by its sourcing practices from India. The company's reliance on a limited number of suppliers, such as PIRAMAL PHARMA LIMITED, which accounts for 64.2% of the total import value, indicates a concentrated supply chain. While this can lead to streamlined operations and potential cost savings, it also exposes Apotex Corp. to risks associated with supplier-specific issues.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA ensures that all drugs entering the U.S. market meet standards for quality, safety, and effectiveness. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act (FD&C Act), which outlines requirements for drug approval, labeling, and manufacturing practices.

For Indian pharmaceutical companies exporting to the U.S., obtaining FDA approval for their products is mandatory. This process involves submitting an Abbreviated New Drug Application (ANDA) for generics, demonstrating bioequivalence to the reference listed drug. Manufacturing facilities must also be registered with the FDA and comply with Good Manufacturing Practice (GMP) regulations. The FDA conducts inspections to verify compliance with these standards, and products failing to meet requirements may be refused entry into the U.S. market.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA. All foreign drug establishments whose products are imported into the U.S. must register with the FDA and list all their drug products in commercial distribution. This registration ensures that the FDA is notified of all regulated products imported into the United States.

Apotex Corp — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Apotex Corp.'s product strategy focuses on therapeutic areas with high demand and significant market potential. The company's imports from India predominantly include cardiovascular medications, vitamins and supplements, and oncology drugs. This strategic focus aligns with the growing prevalence of cardiovascular diseases, the aging population's need for supplements, and the ongoing demand for cancer treatments. By concentrating on these areas, Apotex Corp. aims to address critical healthcare needs and capture substantial market share in the U.S. pharmaceutical sector.

2Sourcing Profile

Apotex Corp.'s sourcing strategy emphasizes the procurement of generic drugs from India, leveraging the country's established pharmaceutical manufacturing capabilities. The company imports a diverse range of formulations, with 492 unique products sourced from seven Indian suppliers. This approach allows Apotex Corp. to offer a broad portfolio of medications, catering to various therapeutic needs. India's competitive

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Apotex Corp

What products does Apotex Corp import from India?

Apotex Corp imports 4 pharmaceutical products across 4 categories. Top imports: Atorvastatin ($21.4M), Calcium ($14.4M), Paclitaxel ($700.0K), Protein ($700.0K).

Who supplies pharmaceuticals to Apotex Corp from India?

Apotex Corp sources from 7 verified Indian suppliers. The primary supplier is Piramal Pharma Limited (64.2% of imports, $21.7M).

What is Apotex Corp's total pharmaceutical import value?

Apotex Corp's total pharmaceutical import value from India is $37.3M, based on 746 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Apotex Corp focus on?

Apotex Corp imports across 4 categories. The largest: Cardiovascular (57.5%), Vitamins & Supplements (38.7%), Oncology (1.9%).

Get Full Apotex Corp Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.